Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2024 | Integrating multigene testing into advanced breast cancer care

Gabriele Zoppoli • 15 Sep 2024
ESMO 2024
Breast Cancer

Gabriele Zoppoli, MD, PhD, University of Genoa, Genoa, Italy, explores the integration of multigene testing in standard practice for advanced breast cancer. Rebiopsies during disease progression allowing for the identification of actionable mutations such as PI3K and estrogen receptor. Expanding testing panels to include less commonly targeted genes could reveal additional therapeutic targets, facilitating the development of novel agents. This interview took place at the European Society for Medical Oncology (ESMO) 2024 Congress in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Gabriele Zoppoli

Age as a biomarker for targetable mutations in advanced breast cancer
1:18
Age as a biomarker for targetable mutations in advanced breast cancer
Gabriele Zoppoli • 15 Sep 2024
Molecular characterization of breast cancer across age groups in the AURORA program
1:14
Molecular characterization of breast cancer across age groups in the AURORA program
Gabriele Zoppoli • 15 Sep 2024

Related Videos

How will SARMs fit into the current breast cancer treatment paradigm?
1:14
How will SARMs fit into the current breast cancer treatment paradigm?
Rafael Grochot • 2 Jul 2026
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
1:35
Phase I/II trial of vosilasarm and endocrine therapy in AR+/ER+/HER2− breast cancer
Rafael Grochot • 2 Jul 2026
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
1:07
HYPORT: does the number of fractions of RNRT impact the typical symptoms experienced?
Sanjoy Chatterjee • 17 May 2026
Design and aim of the HYPORT study in regional nodal breast cancer
1:23
Design and aim of the HYPORT study in regional nodal breast cancer
Sanjoy Chatterjee • 17 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals